JBS Pushes From Commodity Protein Into Nutrition, Eggs and Biotech
From GLP-1 diets to functional foods, analysts see new growth avenues for the company beyond traditional commodity cycles.
From GLP-1 diets to functional foods, analysts see new growth avenues for the company beyond traditional commodity cycles.
The company reduced its 2026 investment plan by $400 million, targeted margin gains in U.S. beef and pointed to Seara and Australia as levers…